ABLYNX NV's ticker is ABLX and the CUSIP is 00372Y105. A total of 40 filers reported holding ABLYNX NV in Q1 2018. The put-call ratio across all filers is 130.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,617,000 | – | 65,000 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 637,884 | $15,941,000 | 2.94% |
| Eversept Partners, LP | 100,879 | $2,520,966 | 1.45% |
| Iguana Healthcare Management, LLC | 65,000 | $1,617,000 | 1.05% |
| Baker Brothers Advisors | 4,161,118 | $103,986,000 | 0.90% |
| MARSHALL WACE, LLP | 525,385 | $13,129,000 | 0.55% |
| Ghost Tree Capital, LLC | 90,000 | $2,249,000 | 0.53% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,350,000 | $58,727,000 | 0.48% |
| Schonfeld Strategic Advisors LLC | 226,275 | $5,655,000 | 0.46% |
| Granahan Investment Management | 186,690 | $4,665,000 | 0.37% |
| PURA VIDA INVESTMENTS, LLC | 29,399 | $735,000 | 0.31% |